The University of Central Florida and Limbitless Solutions partner to develop the technology and move it into commercialization.
The University of Central Florida and Limbitless Solutions partner to develop the technology and move it into commercialization.
The device tax, regulatory scrutiny, and a failure to address unmet clinical needs are among the reasons that the United States will fall behind other major markets.
The device tax, regulatory scrutiny, and a failure to address unmet clinical needs are among the reasons that the United States will fall behind other major markets.
Johnson & Johnson holds firm that it will continue to accelerate in the innovation department over the next year.
Johnson & Johnson holds firm that it will continue to accelerate in the innovation department over the next year.
IBM’s Watson Health Unit is forming several collaborations to facilitate personalized health on a massive scale.
IBM’s Watson Health Unit is forming several collaborations to facilitate personalized health on a massive scale.
Innovative Publishing names new face for Medical Device Summit and Food Safety Tech.
Innovative Publishing names new face for Medical Device Summit and Food Safety Tech.
FDA has granted a first-of-its-kind expanded approval for Medtronic’s CoreValve System for valve-in-valve replacement.
FDA has granted a first-of-its-kind expanded approval for Medtronic’s CoreValve System for valve-in-valve replacement.
When launching a new product, manufacturers may want to consider Canada first.
When launching a new product, manufacturers may want to consider Canada first.
With decreasing prices and increasing regulation, many UK medical device businesses are looking to emerging markets for growth. However, compliance issues are also problematic in those territories, according to a recent study from life science consulting firm Maetrics.
With decreasing prices and increasing regulation, many UK medical device businesses are looking to emerging markets for growth. However, compliance issues are also problematic in those territories, according to a recent study from life science consulting firm Maetrics.
The market value for transcatheter heart valves will exceed $3 billion by 2020, and adoption of next-generation valves will drive significant market growth, provided that positive clinical data continues, according to research and consulting firm GlobalData.
The market value for transcatheter heart valves will exceed $3 billion by 2020, and adoption of next-generation valves will drive significant market growth, provided that positive clinical data continues, according to research and consulting firm GlobalData.
Using subcutaneous leads, rather than leads threaded through blood vessels to the heart, the EMBLEM Subcutaneous Implantable Defibrillator model is 19 percent slimmer and projected to last 40 percent longer than the original S-ICD, according to the company.
Using subcutaneous leads, rather than leads threaded through blood vessels to the heart, the EMBLEM Subcutaneous Implantable Defibrillator model is 19 percent slimmer and projected to last 40 percent longer than the original S-ICD, according to the company.
